Latest Period
Q1 2026
Security Snapshot
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) Institutional Ownership
CUSIP: 64130M209
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
31
Shares (Excl. Options)
11,774,850
Price
$0.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- NMTC on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 11,774,850
- Total 13F value
- $9,144,296
- Portfolio coverage rank
- 0%
- Share change
- -804,556
- Value change
- -$618,566
- Number of holders
- 31
- Shares outstanding
- 8,477,622
- SEC-reported price per share
- $0.78
- Insider filing price
- $0.78
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock is tracked under CUSIP 64130M209.
- 31 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 37 to 31 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $9,437,810 to $9,144,296.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 31 institutions filings for Q1 2026.
Security key
64130M209
Latest holder period
Q1 2026
13F holders
31
13D/G owners
8
CIK / CUSIP context first
Open Q1 2026 holders
NMTC full holder history
NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
NEUROONE MEDICAL TECHNOLOGIES Corp company facts
NEUROONE MEDICAL TECHNOLOGIES Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 64130M209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
NMTC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MERCHANT ADVENTURE FUND, L.P. | 14% | $2,478,000 | 4,200,000 | MERCHANT ADVENTURE FUND, L.P. | 31 Dec 2024 | |||
| Bleichroeder LP | 8% | $2,800,000 | 4,000,000 | Bleichroeder LP | 30 Jun 2025 | |||
| Sio Capital Management, LLC | 4.7% | -34% | $2,098,132 | -$1,033,699 | 2,360,635 | -33% | Sio Capital Management, LLC | 30 Sep 2025 |
| AWM Investment Company, Inc. | 4.8% | $1,388,959 | 2,354,167 | AWM Investment Company, Inc. | 31 Mar 2025 | |||
| MANCHESTER MANAGEMENT CO LLC | 4.9% | $934,166 | 1,583,332 | JAMES E. BESSER | 31 Dec 2024 | |||
| LYTTON LAURENCE W | 2.6% | $764,220 | 1,295,288 | LYTTON LAURENCE W | 31 Mar 2025 | |||
| Nantahala Capital Management, LLC | 2.6% | $471,270 | 798,762 | Nantahala Capital Management, LLC | 30 Sep 2024 | |||
| Pratt Brian | 7.4% | $487,133 | 627,344 | Brian Pratt | 14 Apr 2026 |
As of 31 Mar 2026, 31 institutional investors reported holding 11,774,850 shares of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC). This represents 139% of the company’s total 8,477,622 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
139%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bleichroeder LP | 47% | 4,000,000 | 0% | 0.54% | $3,106,000 |
| BARD ASSOCIATES INC | 22% | 1,840,498 | -0.35% | 0.36% | $1,429,147 |
| PERKINS CAPITAL MANAGEMENT INC | 17% | 1,473,000 | 0% | 1.1% | $1,143,784 |
| VANGUARD CAPITAL MANAGEMENT LLC | 16% | 1,397,329 | 0% | 0% | $1,085,725 |
| RENAISSANCE TECHNOLOGIES LLC | 7.7% | 655,446 | -14% | 0% | $508,954 |
| GEODE CAPITAL MANAGEMENT, LLC | 7.3% | 615,606 | +22% | 0% | $478,075 |
| Sio Capital Management, LLC | 5.9% | 496,614 | -56% | 0.06% | $385,621 |
| VANGUARD FIDUCIARY TRUST CO | 3.4% | 292,081 | 0% | 0% | $226,947 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 3.1% | 261,953 | +39% | 0.03% | $203,407 |
| Cambridge Investment Research Advisors, Inc. | 2% | 171,000 | 0% | 0% | $133,000 |
| NORTHERN TRUST CORP | 1.3% | 112,123 | 0% | 0% | $87,064 |
| Belpointe Asset Management LLC | 0.88% | 75,000 | 0% | $58,238 | |
| Legato Capital Management LLC | 0.73% | 61,642 | +39% | 0% | $47,865 |
| STATE STREET CORP | 0.7% | 59,499 | 0% | 0% | $46,201 |
| XTX Topco Ltd | 0.51% | 43,283 | -49% | 0% | $33,609 |
| J.W. COLE ADVISORS, INC. | 0.42% | 36,000 | 0% | 0% | $27,954 |
| Focus Financial Network, Inc. | 0.41% | 34,722 | 0% | 0% | $26,962 |
| TWO SIGMA SECURITIES, LLC | 0.29% | 24,764 | 0% | $19,229 | |
| United Community Bank | 0.24% | 20,000 | 0% | 0.01% | $15,530 |
| Revisor Wealth Management LLC | 0.23% | 19,580 | 0% | $15,204 | |
| Arch Global Advisors, LLC | 0.21% | 17,434 | 0% | 0.01% | $13,538 |
| Princeton Global Asset Management LLC | 0.2% | 16,833 | 0% | 0% | $13,071 |
| LPL Financial LLC | 0.18% | 15,034 | +37% | 0% | $11,674 |
| MORGAN STANLEY | 0.14% | 12,096 | -53% | 0% | $9,393 |
| Mariner, LLC | 0.12% | 10,420 | -0.12% | 0% | $8,091 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 11,774,850 | $9,144,296 | -$618,566 | $0.78 | 31 |
| 2025 Q4 | 12,450,799 | $9,437,810 | -$1,624,435 | $0.76 | 37 |
| 2025 Q3 | 14,406,380 | $12,801,427 | +$798,232 | $0.89 | 34 |
| 2025 Q2 | 13,532,500 | $9,178,137 | +$7,852,763 | $0.68 | 30 |
| 2025 Q1 | 1,929,327 | $1,640,294 | +$267,014 | $0.85 | 18 |
| 2024 Q4 | 1,618,518 | $1,336,454 | -$822,631 | $0.83 | 20 |
| 2024 Q3 | 2,423,467 | $2,399,034 | -$268,422 | $0.99 | 21 |
| 2024 Q2 | 2,735,360 | $2,187,702 | -$97,024 | $0.80 | 18 |
| 2024 Q1 | 2,846,820 | $3,416,201 | -$33,927 | $1.20 | 18 |
| 2023 Q4 | 2,862,898 | $4,523,339 | +$578,694 | $1.58 | 20 |
| 2023 Q3 | 2,618,184 | $2,331,807 | +$1,492,764 | $0.89 | 18 |
| 2023 Q2 | 938,623 | $1,126,777 | -$44,391 | $1.20 | 13 |
| 2023 Q1 | 962,913 | $1,549,540 | +$453,337 | $1.61 | 14 |
| 2022 Q4 | 722,249 | $866,359 | +$155,582 | $1.20 | 18 |
| 2022 Q3 | 409,378 | $686,000 | +$3,717 | $1.69 | 9 |
| 2022 Q2 | 479,839 | $394,000 | -$269,817 | $0.82 | 8 |
| 2022 Q1 | 707,048 | $777,000 | -$2,285,922 | $1.10 | 8 |
| 2021 Q4 | 1,946,125 | $3,774,000 | +$3,070,716 | $1.94 | 12 |
| 2021 Q3 | 250,733 | $989,000 | -$398,000 | $3.94 | 6 |
| 2021 Q2 | 411,124 | $1,522,205 | +$1,521,000 | $6.63 | 3 |